Zhejiang AngLiKang Pharmaceutical CO.,LTD. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers chemical raw materials for pharmaceuticals comprising oral cephalosporin antibiotic raw materials, including cephalexin, cefadroxil, cefaclor, and cefadroxil; alpha-keto acid raw materials; inhaled anesthetic raw materials, such as isoflurane and sevoflurane; and anti-androgen intermediates, including finasteride and dutasteride. It also provides chemical agents consisting of anti-infective preparations, such as cefixime and cefadroxil capsules, cefaclor sustained-release tablets, cefaclor granules, and cefalexin capsules; cardiovascular preparations, including levamlodipine besylate and amlodipine besylate tablets, nifedipine sustained-release and sacubitril/valsartan sodium tablets, and measartan potassium and ticagrelor tablets; anesthetic and analgesic preparations, such as sevoflurane inhalation, liprocaine cream, and pregabalin capsules; nephropathy preparations, including compound a-keto acid tablets, levocarnitine oral solutions, and lanthanum carbonate chewable tablets; oryzanol and doxofylline tablets; and other products. In addition, the company offers specialty intermediates, such as plant-derived cholesterol and its derivatives, plant-derived vitamin D3, and plant-derived 25-hydroxyvitamin D3. Further, it provides lyophilized powder injections, steroidal biological products, and plant extracts; penicillin; and active pharmaceutical ingredients (APIs) for respiratory system, digestive system, and pain indications. Additionally, the company engages in biotechnology promotion activities. The company serves pharmaceutical companies, commercial and pharmaceutical distribution companies, chemical and nutritional companies, and feed companies. Zhejiang AngLiKang Pharmaceutical CO.,LTD. was founded in 2001 and is headquartered in Shengzhou, China.
